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Abstract. The diagnosis of iron deficiency anemia in malaria endemic areas is complicated by the influence of
the infection on the laboratory tests conventionally used to assess iron status. Determination of soluble transferrin
receptor (sTfR) levels has been shown to be a sensitive indicator of iron deficiency in adults and is not affected by
a range of infectious and inflammatory conditions. The utility of sTfR levels in the diagnosis of iron deficiency in
malaria endemic areas remains unresolved.
Three hundred and fourteen infants in a rural area of southern Tanzania living under conditions of intense and
perennial malaria transmission were studied to determine the utility of sTfR plasma levels in the assessment of iron
deficiency anemia. Independent of the presence of anemia, malaria parasitemia was associated with a significant
increase in sTfR plasma levels that were even higher than those found in iron deficiency anemia. We conclude that
the measurement of sTfR levels does not have a role in the diagnosis of iron deficiency anemia in young children
exposed to malaria infection.
INTRODUCTION
Iron deficiency is the most common cause of anemia and
the most prevalent nutritional problem worldwide.1 Iron de-
ficiency anemia is especially common in developing regions
where infants, young children, and pregnant women are par-
ticularly at risk. Malaria infection is another major cause of
anemia affecting the same populations. The geographic dis-
tribution of iron deficiency anemia and malaria transmission
often overlap. Malaria infection affects the conventional lab-
oratory tests of iron status such as plasma iron, ferritin, total
iron binding capacity (TIBC) and transferrin saturation.2 Be-
cause of hemolysis, plasma iron may be also increased in
malaria infection.3 Due to the complexity in the interpreta-
tion and the lack of specificity of the available tests for iron
status determination, the clinical management of the anemic
patient in malarious areas usually includes an empiric com-
bination of treatments for anemia aimed at the most common
causes. This influences the quality of health care as well as
having important economic implications for the health sec-
tor. In the absence of definitive confirmation of iron defi-
ciency through bone marrow examination, there is a need
for non-invasive and specific tests especially in areas where
iron deficiency is highly prevalent.
Together with ferritin concentration, soluble transferrin re-
ceptor (sTfR) serum levels have been suggested to be sen-
sitive indicators of iron status in adults.4 Unlike other labo-
ratory tests of iron status (such as plasma ferritin, iron,
TIBC, and transferrin saturation), sTfR levels are not af-
fected by infectious or inflammatory conditions, or pregnan-
cy, in the absence of iron deficiency.5 In recent years the
determination of sTfR levels has been proposed as a useful
new tool in the diagnosis of iron deficiency in anemic pa-
tients.5 Serum levels of sTfR were increased in anemic adult
patients with iron deficiency either with or without an as-
sociated inflammatory condition, while they were within the
normal range in those with chronic infectious or inflamma-
tory diseases alone.6
There have been very few reports on the usefulness of
sTfR levels in the diagnosis of iron deficiency in children7
and only two from malaria endemic areas. These studies had
contradictory results.8,9 One suggested that sTfR levels were
not affected by malaria;8 the other observed that sTfR levels
were significantly lower.9 Differences in the prevalence of
iron deficiency and hemoglobinopathies, malaria endemicity
and the age groups of the individuals studied were proposed
to account for these discrepancies. Neither of these studies
focused on infants, the group most affected by both iron
deficiency and malaria anemia in highly endemic areas.10,11
We have therefore investigated the usefulness of sTfR levels
in infants exposed to intense malaria transmission to assess
iron deficiency anemia. These infants were originally en-
rolled into an intervention trial for the prevention of malaria
and anemia.
MATERIALS AND METHODS
Study area and population. The study took place in the
town of Ifakara, Kilombero district in southeastern Tanzania.
The demographic characteristics and malaria epidemiology
of the area have been described in detail elsewhere.12 In
brief, malaria transmission is intense and perennial with an
estimated entomological inoculation rate (EIR) of 300 infec-
tive bites per person per year in a nearby village.13 Clinical
malaria is one of the main causes of hospital admission in
children, the majority of cases and deaths occurring in in-
dividuals less than 1 year of age.11 Of the admitted children,
35% of those less than 5 years old and 41% of those less
than 1 year of age had moderate or severe anemia (Menen-
dez C and others, unpublished data). A recent intervention
study carried out in this area identified malaria as responsible
for about 60% of severe anemia episodes (packed cell vol-
ume [PCV]  25%) in infants; iron deficiency accounted for
about 30% of such episodes.14
Study design and definitions. The current study was part
of a randomized placebo-controlled trial of malaria chemo-
prophylaxis and iron supplementation for the prevention of
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TABLE 1
Definitions
Clinical malaria Plasmodium falciparum parasitemia of
any density and axillary temperature
37.5C
Asymptomatic malaria P. falciparum parasitemia of any density
with an axillary temperature 37.5C
Iron deficiency
Plasma ferritin  10 (ng/mL) and/or
Plasma iron  11 (g/dL) and Plasma
transferrin concentration  347 (mg/dL)
Anemia PCV  33%
Inflammation C-reactive protein (CRP)  0.8 mg/dl
Microcytosis Mean corpuscular volume (MCV)  70 fl
TABLE 2
Prevalence of hematologic and parasitologic variables in study chil-
dren at 8 months of age
n/N (%)
Hb Genotype AS
Malaria parasitemia*
Iron deficiency†
Anemia (PCV  33%)
Inflammation (CRP  0.8 mg/dL)
Microcytosis (MCV  70 fl)
39/125 (31.2)
48/314 (15.3)
37/314 (11.8)
145/312 (46.5)
98/305 (32.1)
132/284 (46.5)
* Asexual Plasmodium falciparum.
† Plasma ferritin  10 (ng/mL) and/or Plasma iron  11 (g/dL) and Plasma transferrin
concentration  347 (mg/dL).
PCV  packed cell volume; MCV  mean corpuscular volume; CRP  C-reactive pro-
tein.
malaria and anemia in infants. Children were randomized at
two months of age to receive iron supplements, malarial che-
moprophylaxis or placebo for 4 and 10 months respective-
ly.14 Soluble transferrin receptor levels were measured in 314
randomly selected infants of the 611 (51%) who were visited
at 8 months of age. At this visit, finger prick blood samples
were collected for hematological, biochemical and parasi-
tological analysis. Definitions used in the study are presented
in Table 1.
Informed consent was obtained from all parents or guard-
ians of the study infants. The study received ethical clear-
ance from the Tanzanian Commission for Science and Tech-
nology and from the Ethical Committee of the Hospital Clin-
ic in Barcelona.
Laboratory procedures. Blood samples were collected
into EDTA and heparin microtainers (Becton Dickinson) and
the separated plasma stored at 20C. Plasma soluble trans-
ferrin receptor levels were measured by an enzyme immu-
noassay using a kit from Orion Diagnostica (Espoo, Fin-
land); according to the manufacturer the 25th and 97.5th per-
centiles of the reference distribution range for the kit were
1.3 and 3.3 mg/L respectively. Plasma ferritin was measured
by a radioimmunoassay (Tandem-R Ferritin, Hybritech Inc,
San Diego, CA); for the kit, the normal range for children
of this age was 10–83 ng/mL. Plasma iron (reference range
11–150 g/dl) was measured colorimetrically using the fer-
rozine method without deproteination (Roche Diagnostics,
Basel, Switzerland) in a Cobas Mira S analyzer. Plasma
transferrin (reference range 218–347 mg/dl) and C-reactive
protein were assayed by immunonephelometric methods
(Dade Behring, Marburg, Germany).
Blood counts, hemoglobin (Hb), PCV, and the mean cor-
puscular volume (MCV) were determined on a semiauto-
matic cell counter (Sysmex F800 microcell counter, TOA
Medical Electronics, Kobe, Japan).
Thick and thin blood films were stained and read for ma-
laria parasites following standard, quality-controlled proce-
dures.12 Hemoglobin electrophoresis was performed on cel-
lulose acetate strips.
Statistical methods. Variables were compared between
the anemia groups using regression analysis. The model was
adjusted for the treatment groups. Spearman’s test was used
for correlation analysis. Student’s t-test was used to compare
MCV values. Logarithmic transformation was done for var-
iables that were not normally distributed: PCV, ferritin, iron,
transferrin concentration, sTfR, and C-reactive protein and
parasite density. Statistical analysis was done using Stata
Statistical Software version 5.0 (Stata Corporation, College
Station, TX).
RESULTS
Children were grouped according to the presence of ane-
mia, iron deficiency, and malaria. Infants in group I (control
group) did not have anemia, iron deficiency, or malaria (n
 142); group II were those with anemia alone (n  86);
group III had iron deficiency anemia (IDA) (but not malaria)
(n  25); and group IV had anemia plus malaria (but not
iron deficiency) (n  34). The remaining 27 infants in whom
sTfR levels were measured belonged to two or more cate-
gories; that is, they were either anemic or not anemic with
iron deficiency and malaria.
Hemoglobin genotype results were available in 125 chil-
dren of whom 39 (31.2%) had the genotype AS (this prev-
alence is higher than that previously reported from the area14
and it is probably due to chance variation in the selection of
the sample). Soluble transferrin receptor levels did not differ
significantly by sex, presence of fever, microcytosis or Hb
genotype (Menendez C and others, unpublished data). For
this reason, analysis was done without distinction between
these variables.
Hematological and parasitological features of the study
population are shown in Table 2. The geometric mean sTfR
level in the overall sample of children was 4.1 ng/ml
(95%CI: 3.9–4.3). STfR levels correlated directly with trans-
ferrin concentration (r  0.35; P  0.001) and inversely with
PCV (r  0.40; P  0.001) and iron (r  0.10), although
the latter correlation was of borderline significance (P 
0.07). There was also a direct and significant correlation with
the density of parasitemia (r  0.36; P  0.001). When
compared with the control group, mean geometric sTfr levels
were significantly higher in non-anemic children who had
malaria infection (3.4 [95%CI: 3.2–3.6] versus 5.4 [95%CI:
3.9–7.6]; P  0.001).
Hematological parameters (PCV and MCV), ferritin, iron,
transferrin concentration, C-reactive protein, and sTfR were
compared between the different categories of anemia using
multiple regression analysis adjusting for the treatment
group (Table 3). Mean sTfR concentrations were signifi-
cantly lower in all intervention groups compared to the pla-
cebo group (Menendez C and others, data not shown). The
analysis showed that both IDA and malaria-anemia were in-
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TABLE 3
Hematologic and biochemical parameters in the study infants by anemia group
Group I
(Control)
Group II
(Anemia alone)
Group III
(IDA)
Group IV
(Malarial-anemia) Miscellaneous group
PCV (%)† 36.9
(36.2, 37.6)
30.0***
(29.4, 30.6)
29.9***
(29.1, 30.7)
27.1***
(25.8, 28.4)
36.4
(35.3, 37.5)
MCV (fL)‡ 72.1
(6.7)
69.6*
(6.6)
65.4**
(7.6)
71.4
(7.1)
71.8
(7.4)
Plasma iron (g/dL)† 37.9
(35.0, 41.1)
35.2
(31.8, 39.1)
23.9***
(18.3, 31.3)
38.5
(30.7, 48.3)
37.8
(30.1, 47.6)
Plasma ferritin (ng/mL)† 37.6
(33.1, 42.8)
35.7
(29.6, 43.0)
8.1***
(5.9, 11.2)
62.7***
(43.6, 90.2)
23.1*
(13.5, 39.7)
Plasma transferrin concentration (mg/dL)† 322.5
(313.9, 331.3)
326.5
(316.2, 337.2)
376.0***
(361.4, 391.3)
355.0**
(336.4, 374.6)
358.0**
(342.8, 373.7)
C-reactive protein (mg/dL)† 0.7
(0.6, 0.8)
0.8
(0.7, 0.9)
0.7
(0.5, 1.0)
1.5***
(1.0, 2.3)
0.8
(0.6, 1.1)
sTfR (ng/mL)† 3.4
(3.2, 3.6)
4.2**
(3.8, 4.6)
5.4***
(4.6, 6.3)
6.8***
(5.8, 7.9)
4.5**
(3.8, 5.4)
PCV  packed cell volume; MCV  mean corpuscular volume; sTfR  soluble transferrin receptor; anemia  PCV  33%; IDA  iron deficiency anemia; miscellaneous group  anemic
or non-anemic with iron deficiency and malaria.
* P  0.05 versus controls adjusted for treatment group.
** P  .01 versus controls adjusted for treatment group.
*** P  0.001 versus controls adjusted for treatment group.
† Data expressed as geometric mean (95% confidence interval).
‡ Data expressed as arithmetic mean (SD).
FIGURE 1. The receiving operating characteristics (ROC) curves
for sTfR in the identification of children with either malaria-related
anemia or IDA. The measurement of sTfR levels gives a sensitivity
and specificity greater than 80% in the identification of patients with
malaria (A) while sensitivity and specificity could not be obtained
simultaneously in the identification of patients with iron deficiency
(B).
dependently associated with a significant increase in sTfR
concentrations. The highest levels of sTfR were in the ane-
mic infants who also had malaria parasitemia. Anemia with-
out malaria infection or iron deficiency was also associated
with a smaller but significant increase in sTfR levels (Table
3). Mean sTfR levels were significantly higher in the malar-
ia-anemia group compared to the anemia alone group (P 
0.001).
Mean PCV was significantly lower in the malaria-anemia
group than in the other two anemic groups (P  0.05), while
MCV was lower in IDA and anemia alone groups. Plasma
ferritin was significantly higher in the malaria-anemia group.
Transferrin concentration was significantly higher in both
malaria-anemia and IDA categories. C-reactive protein was
significantly increased only in children with both anemia and
malaria infection (Table 3).
Figure 1 shows the receiving operating characteristics
(ROC) curves for sTfR in the identification of children with
either malaria-related anemia or IDA. ROC curves evaluate
the sensitivity and specificity of a test taking every value of
the sample as a cut-off point to discriminate between two
groups. This figure shows that the measurement of sTfR lev-
els gives a sensitivity and specificity greater than 80% in the
identification of patients with malaria (A), while sensitivity
and specificity could not be obtained simultaneously in the
identification of patients with iron deficiency (B).
DISCUSSION
This study found that malaria infection was associated
with a significant increase in sTfR plasma levels, even above
those found in iron deficiency anemia and independent of a
concomitant reduction in mean PCV level. This could be
solely explained by the hemolysis associated with infection.
The direct correlation found between sTfR levels and para-
site density supports this. It could be argued that the high
sTfR concentration associated with malaria infection could
have been a misclassification of some iron deficient children
in the absence of a gold standard test for iron deficiency
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such as bone marrow examination. However, a significantly
(P  0.001) lower MCV in the IDA group compared to the
malaria-anemia group is consistent with the assumption that
children were correctly classified in this study. It is unlikely
that in clinical practice the diagnosis of iron deficiency ane-
mia would be more detailed than it has been in this study.
Plasma sTfR levels are higher in conditions with high
erythropoietic activity such as hemolytic conditions (includ-
ing hemoglobinopathies, congenital hemolytic anemias and
traumatic hemolysis), iron deficiency, ineffective erythro-
poiesis and megaloblastic anemia.5,15–17 In one study, a sig-
nificant positive correlation was seen between sTfR and
erythropoietin levels in patients with IDA,5 suggesting that
increased erythropoietin production could stimulate the syn-
thesis of sTfR.
Our findings are in disagreement with two other studies
carried out among malaria exposed individuals in which
plasma sTfR levels were either significantly decreased or not
different in the presence of clinical malaria.8,9 Suppression
of the bone marrow response to erythropoietin or its defi-
ciency were proposed to explain the decrease in plasma sTfR
levels in individuals with clinical malaria in Vanuatu.9 How-
ever, increased serum erythropoietin levels have been re-
ported in African children with severe malarial anemia18 and
this may be in keeping with the finding of high sTfR levels
in association with malaria infection reported in our study.
Erythrocyte progenitor cells are considered the main source
of transferrin receptors in the body, and the fact that these
receptors are increased in malaria may reflect an active ery-
throid marrow and would argue against the hypothesis that
erythropoiesis is inhibited in malaria.19,20 Reticulocyte counts
(which reflect the activity of the erythroid marrow) were
found to be decreased in some studies but were normal or
increased in others in association with malaria infection, sug-
gesting furthermore that the erythropoietic activity in the
bone marrow may be enhanced by malaria infection.21,22
Other reasons may explain the discrepancy between the
other two studies in malaria endemic areas and ours regard-
ing sTfR levels. First, in the current study, anemic patients
were compared with a control group without anemia whereas
in the other two studies the groups were not differentiated
on the basis of anemia. Different malaria endemicity levels
as well as differences in the age of the subjects studied may
also contribute to these discrepancies. It is unlikely that the
high prevalence of the Hb genotype AS in our study could
account for the increased sTfR levels in malaria-infected,
anemic children, since sTfR concentration was similar in Hb
AA (geometric mean, 95% CI  4.4 ng/ml, 3.9–4.8) and
AS children (geometric mean, 95% CI  3.8 ng/ml, 3.3–
4.5). Furthermore, the proportion of children with the Hb
genotype AS was lower among those with malarial-anemia
than in the other two anemic and control groups (Menendez
C and others, data not shown).
The presence of subpatent malaria parasitemia, or alter-
natively a malaria infection that has been recently resolved,
may explain the moderate but significant increase in sTfR
levels in the group with anemia but without malaria or iron
deficiency. It is known that the hemolysis of malaria infec-
tion may last for days or weeks after the parasitemia has
been cleared.23 Therefore, the hematological effects of ma-
laria may remain, even though parasites are not detected on
a blood smear examination.
This study has presented data showing that the measure-
ment of plasma sTfR concentration does not have a role
either in individual or population level assessment of iron
deficiency in malaria endemic areas, at least in the age group
with the highest prevalence of anemia and iron deficiency.
Therefore, the accurate detection of iron deficiency anemia
in malaria endemic regions by non-invasive methods re-
mains unresolved and more research is needed to find a di-
agnostic test which helps improving the clinical management
of the anemic patients in these areas.
Acknowledgments: We thank the parents and guardians of all chil-
dren involved in the study, the staff of the Ifakara Health Research
and Development Centre and the St. Francis Designated District
Hospital, and Dr F Lwila and his District Health Management Team.
We are also grateful to the staff of the Nuclear Medicine lab of the
Hospital Clinic for testing the plasma ferritin levels. We especially
thank Professor Alan Fleming for valuable comments on the man-
uscript.
Financial support: The study was supported through grants of the
UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases, the Spanish Agency for International
Cooperation (AECI), and Fondo de Investigaciones Sanitarias. Ifak-
ara Health Research and Development Center and St Francis Des-
ignated District Hospital receive funding from the Swiss Agency for
Development and Cooperation, AECI, and the Government of Tan-
zania.
Author’s addresses: Clara Menendez, Llorenc¸ Quinto, John J Apon-
te, and Pedro L Alonso, Unidad de Epidemiologia y Bioestadistica,
Hospital Clinic/Institut d’Investigaciones Biome`diques August Pi i
Sunyer (IDIBAPS), Villarroel 170, 08036 Barcelona, Spain, Tel: 93
2275706, Fax: 93 4515272. Elizeus Kahigwa and David Schellen-
berg, Ifakara Health Research and Development Centre, PO Box 53,
Ifakara, Tanzania. Luisa Alvarez and Nuria Gimenez, Departamento
de Bioquimica Clinica, Hospital Clinic/Institut d’Investigaciones
Biome`diques August Pi i Sunyer (IDIBAPS), Villarroel 170, 08036
Barcelona, Spain, Tel: 93 2035706, Fax: 93 4515272. Rosa Fernan-
dez, Departamento de Medicina Nuclear, Hospital Clinic/Institut
d’Investigaciones Biome`diques August Pi i Sunyer (IDIBAPS), Vil-
larroel 170, 08036 Barcelona, Spain, Tel: 93 2035706, Fax: 93
4515272. Marcel Tanner, Swiss Tropical Institute, Socinstrasse 57,
Ch 4051, Basel, Switzerland, Tel: 61 2848283, Fax: 61 2717951.
REFERENCES
1. Stoltzfus RJ, Dreyfuss ML, 1998. Guidelines for the use of iron
supplements to prevent and treat iron deficiency anemia. In-
ternational Nutritional Anemia Consultative Group (INACG),
World Health Organisation (WHO), United Nations Chil-
dren’s Fund (UNICEF).
2. Das BS, Thurnham DI, Das DB, 1997. Influence of malaria on
markers of iron status in children: Implications for interpret-
ing iron status in malaria-endemic communities. Br J Nutr
78: 751–760.
3. Ayatse JO, Ekanem EE, 1994. Plasmodium falciparum malaria:
its effects on some haematological parameters in normal and
sickle cell Nigerian children. Trop Med Parasitol 45: 219–
222.
4. Skikne BS, Flowers CH, Cook JD, 1990. Serum transferrin re-
ceptor: a quantitative measure of tissue iron deficiency. Blood
75: 1870–1876.
5. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD,
1991. Serum transferrin receptor distinguishes the anemia of
chronic disease from iron deficiency anemia. J Lab Clin Med
119: 385–390.
6. Punnonen K, Irjala K, Rajama¨ki A, 1997. Serum transferrin re-
142 MENENDEZ AND OTHERS
ceptor and its ratio to serum ferritin in the diagnosis of iron
deficiency. Blood 89: 1052–1057.
7. Yeung GS, Zlotkin SH, 1997. Percentile estimates for transferrin
receptor in normal infants 9–16 months of age. Am J Clin
Nutr 66: 342–347.
8. Kuvibidila S, Mark JA, Warrier RP, Yu L, Ode D, Tshefu KA,
1995. Soluble transferrin receptor as an index of iron status
in Zaı¨rian children with malaria. J Trop Med Hyg 98: 373–
378.
9. Williams TN, Maitland K, Rees DC, Peto TE, Bowden DK,
Weatherall DJ, Clegg JB, 1999. Reduced soluble transferrin
receptor concentrations in acute malaria in Vanuatu. Am J
Trop Med Hyg 60: 875–878.
10. Fleming AF, 1981. Iron deficiency in the tropics. Clin Haemat
11: 365–388.
11. Schellenberg D, Menendez C, Kahigwa E, Font f, Galindo C,
Acosta C, Armstrong-Schellenberg J, Aponte JJ, Kimario J,
Urassa H, Mshinda H, Tanner M, Alonso P, 1999. African
children with malaria in an area of intense Plasmodium fal-
ciparum transmission: features on admission to the hospital
and risk factors for death. Am J Trop Med Hyg 61: 431–438.
12. Alonso PL, Smith T, Armstrong Schellenberg JRM, Masanja H,
Mwankusye S, Urassa H, Bastos de Azevedo I, Chongela J,
Kobero S, Menendez C, Hurt N, Thomas MC, Lyimo E,
Weiss NA, Hayes R, Kitua AY, Lopez MC, Kilama WL,
Teuscher T, Tanner M, 1994. Randomised trial of efficacy of
SPf66 vaccine against Plasmodium falciparum malaria in
children in southern Tanzania. Lancet 344: 1175–1181.
13. Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley
P, Muwissen J, Lyimo E, Takken W, Teuscher T, Tanner M,
1993. Absence of seasonal variation in malaria parasitaemia
in an area of intense seasonal transmission. Acta Trop 54: 55–
72.
14. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font
F, Acosta CJ, Schellenberg DM, Galindo CM, Kimario J, Ur-
assa H, Brabin B, Smith TA, Kitua AY, Tanner M, Alonso
PL, 1997. Randomised placebo-controlled trial of iron sup-
plementation and malaria chemoprophylaxis for prevention of
severe anemia and malaria in Tanzanian infants. Lancet 350:
844–850.
15. Rees DC, Williams TN, Maitland K, Clegg JB, Weatherall DJ,
1998. Alpha thalassemia is associated with increased soluble
transferrin receptor levels. Br J Haematol 103: 365–369.
16. Ricci G, Martinelli L, Resca D, Perzolli C, Masotti M, Candi
L, Vigano M, 1995. The determination of plasma transferrin
receptor (TfR) in patients with heart valve prosthesis: a useful
evaluation of bone-marrow response to traumatic haemolysis.
Eur J Haematol 54: 200–201.
17. Carmel R, Skikne BS, 1992. Serum transferrin receptors in the
megaloblastic anemia of cobalamin deficiency. Eur J Hae-
matology 49: 246.
18. Burchard GD, Radloff P, Philipps J, Nkeyi M, Knobloch J,
Kremsner PG, 1995. Increased erythropoietin production in
children with severe malarial anemia. Am J Trop Med Hyg
53: 547–551.
19. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M,
1980. The anemia of P. falciparum malaria. Br J Haemat 46:
171–183.
20. Dormer P, Dietrich M, Kern P, Horstmann RD, 1983. Ineffective
erythropoiesis in acute human Plasmodium falciparum ma-
laria. Blut 46: 279–288.
21. Phillips RE, Looreeesuwan S, Warrell A, Lee SH, Karbwang J,
Warell MJ, White NJ, Swasdichai C, Weatherall DJ, 1986.
The importance of anemia in cerebral and uncomplicated ma-
laria: role of complications, dyserythropoiesis and iron se-
questration. Q J Med 227: 305–323.
22. Srichaikul T, Panikbutr N, Jeumtrakul P, 1967. Bone marrow
changes in human malaria. Ann Trop Med Parasitol 61: 40–
51.
23. Phillips RE, Pasvol G, 1992. Anemia of Plasmodium falciparum
malaria. Baillie`re’s Clin Haemat 5: 315–330.
